[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341036-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341036-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cell-fate-regulation-governed-by-p53-friends-or-reversible-foes-in-cancer-therapy","Cell fate regulation governed by p53 - Friends or reversible foes in cancer therapy","","Cancer remains a leading cause of death worldwide, and improved outcomes have come from targeted therapies against key oncogenic drivers combined with chemotherapy, radiotherapy, and immunotherapy. Tumor protein p53 (TP53) encodes the p53 tumor suppressor and coordinates many downstream genes and phenotypes under stress, including cell-cycle arrest, DNA repair, senescence, metabolic control, apoptosis, and autophagy. Evidence also highlights unexpected roles in ferroptosis, immunity, the tumor microenvironment, and microbiome metabolism. This review summarizes recent advances on altered p53 in therapy response and discusses potential p53-targeting strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cell-fate-regulation-governed-by-p53-friends-or-reversible-foes-in-cancer-therapy/341036/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cell-fate-regulation-governed-by-p53-friends-or-reversible-foes-in-cancer-therapy/341036.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the review focus on regarding p53 in cancer therapy?","Question",{"text":63,"@type":64},"It focuses on how tumor protein p53 (TP53) regulates cell fate and how altered p53 modulates responses to chemotherapy, radiotherapy, and immunotherapy, plus potential strategies to target p53 therapeutically.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cellular processes are regulated by p53 under stress?",{"text":68,"@type":64},"The abstract states p53 controls cell-cycle arrest, DNA repair, cellular senescence, metabolic homeostasis, apoptosis, and autophagy.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are p53 functions described as controversial or still enigmatic?",{"text":72,"@type":64},"The abstract notes that about 40 years after discovery, p53 remains somewhat enigmatic and that its evolutionary plasticity is controversial due to the wide and diverse set of biological functions attributed to different regulatory mechanisms.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341036,1790159719,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":107,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","DOI: 10.1002/cac2.12520  \nREVIEW  \nCell fate regulation governed by p53: Friends or reversible foes in cancer therapy  \nBin Song1  Ping Yang1  Shuyu Zhang1,2, 3   \n1 Laboratory of Radiation Medicine, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, P.  \nR. China  \n2The Second Affiliated Hospital of Chengdu Medical College, China National Nuclear Corporation 416 Hospital, Chengdu, Sichuan, P. R. China  \n3 Laboratory of Radiation Medicine, NHC Key Laboratory of Nuclear Technology Medical Transformation, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu, Sichuan, P. R. China  \nCorrespondence  \nShuyu Zhang; No. 17 South People’s Rd, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan, P. R. China.  \nEmail: [zhang.shuyu@hotmail.com](zhang.shuyu@hotmail.com)  \nFunding information  \nNational Natural Science Foundation of China, Grant/Award Number: 82073477; the Young Talent Project of China National Nuclear Corporation, and Scientific Fund for Distinguished Young Scholars in Sichuan Province,  \nGrant/Award Number: 2022JDJQ0051  \nAbstract  \nCancer is a leading cause of death worldwide. Targeted therapies aimed at key oncogenic driver mutations in combination with chemotherapy and radiotherapy as well as immunotherapy have benefited cancer patients considerably. Tumor protein p53 (TP53), a crucial tumor suppressor gene encoding p53, regulates numerous downstream genes and cellular phenotypes in response to various stressors. The affected genes are involved in diverse processes, including cell cycle arrest, DNA repair, cellular senescence, metabolic homeostasis, apoptosis, and autophagy. However, accumulating recent studies have continued to reveal novel and unexpected functions of p53 in governing the fate of tumors, for example, functions in ferroptosis, immunity, the tumor microenvironment and microbiome metabolism. Among the possibilities, the evolutionary plasticity of p53 is the most controversial, partially due to the dizzying array of biological functions that have been attributed to different regulatory mechanisms of p53 signaling. Nearly 40 years after its discovery, this key tumor suppressor remains somewhat enigmatic. The intricate and diverse functions of p53 in regulating cell fate during cancer treatment are only the tip of the iceberg with respect to its equally complicated structural biology, which has been painstakingly revealed. Additionally, TP53 mutation is one of the most significant genetic alterations in cancer, contributing to rapid cancer cell growth and tumor progression. Here, we summarized recent advances that implicate altered p53 in modulating the response to various cancer therapies, including chemotherapy, radiotherapy, and immunotherapy. Furthermore, we also discussed potential strategies for targeting p53 as a therapeutic option for cancer.  \nKEYWORDS  \ncancer, chemotherapy, drug targeting, immunotherapy, p53, tumor suppressor  \nList of abbreviations: 5-FU, 5-fluorouracil; ABCB1, adenosine triphosphate-binding cassette subfamily B member 1; ABCG2, adenosine triphosphate (ATP)-binding cassette efflux transporter G2; ACT, adoptive cell transfer; ALDH, aldehyde dehydrogenase; ALDH1A1,  \naldehyde dehydrogenase 1A1; ALS, amyotrophic lateral sclerosis; AML, acute myeloid leukemia; AML, acute myeloid leukemia; APC, antigen-presenting cell; APL, acute promyelocytic leukemia; ARF-BP1, ADP-ribosylation factor-binding protein 1; ASPP, apoptosis stimulating  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2024 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat-sen University Cancer Center.  \nSONG et al.  \n1  BACKGROUND  \nCancer","cbCaihDp4BoKNM5J","https://ap.wps.com/l/cbCaihDp4BoKNM5J","pdf",6624264,64,"English","# Abstract\n## Key roles of p53 in cell fate\n## p53 functions across cancer stress responses\n## Altered p53 and therapy outcomes\n## Targeting p53 as a therapeutic strategy","[{\"question\":\"What does the review focus on regarding p53 in cancer therapy?\",\"answer\":\"It focuses on how tumor protein p53 (TP53) regulates cell fate and how altered p53 modulates responses to chemotherapy, radiotherapy, and immunotherapy, plus potential strategies to target p53 therapeutically.\"},{\"question\":\"Which cellular processes are regulated by p53 under stress?\",\"answer\":\"The abstract states p53 controls cell-cycle arrest, DNA repair, cellular senescence, metabolic homeostasis, apoptosis, and autophagy.\"},{\"question\":\"Why are p53 functions described as controversial or still enigmatic?\",\"answer\":\"The abstract notes that about 40 years after discovery, p53 remains somewhat enigmatic and that its evolutionary plasticity is controversial due to the wide and diverse set of biological functions attributed to different regulatory mechanisms.\"}]","Cell fate regulation governed by p53 - Friends or reversible foes in cancer therapy | PDF",1790040044,161,[147,151,155,159,163,167,171],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89211634cea3fbed2877789249cb76fa.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb42cf42aeed3d9b9da9b0b7187a0507.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95e0996e1407cc3ca5a4891ca3a17c53.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65ac77af022eb31ea795295fb8059813.webp",980,1287,{"page_no":97,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/009ff776bfd6bfc4b354b01947dadbf7.webp",979,1286,{"page_no":102,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b147fa76356be4e53ec345413f41229.webp",978,1285,{"page_no":107,"url":172,"width":173,"height":174},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e551054e75b673569c42e324e3f87e0a.webp",977,1283]